International symposium “Stem Cell Transplantation in Multiple Sclerosis: Sharing the Experience” is organized with an aim to focus on the new modality of multiple sclerosis treatment – immunosuppressive therapy followed by autologous stem cell transplantation. The symposium will discuss the state-of-the-art and perspectives of the high dose immunosuppressive therapy and autologous hematopoietic stem cell transplantation in MS. It will be a meeting point for neurologists, immunologists, transplantologists, hematologist, specialists in stem cell research to discuss issues related to the topic. The Symposium will provide an opportunity to share knowledge and to throw a light on the challenges and perspectives of the method. The symposium will contribute in improvement in treatment of the patients with multiple sclerosis. There will be a wide range of topics covered within the symposium and some of them are
- Regimens of conditioning: Immunoablation or immunosupression?
- Types of transplantation: autologous or allogenic?
- Posttransplant immunological reconstitution
- Side effects
- Outcome measures: clinical, imaging, patient-reported outcomes
- Post transplant neurorehabilitation
- Long-term follow-up results
- Proposals for cooperative studies
Pirogov National Medical Surgical Center